Prevalence of low abundant drug-resistant variants by ultra-deep sequencing in chronically HIV-infected antiretroviral (ARV)-naive patients and the impact on virological outcomes

被引：0
|
作者：
Simen, B. B.
Hullsiek, K. Huppler [1 ]
Novak, R. M. [2 ]
MacArthur, R. D. [3 ]
Baxter, J. D. [4 ]
Huang, C.
Lubeski, C.
Turenchalk, G. S.
Braverman, M. S.
Desany, B.
Simons, J. F.
Rothberg, J. M.
Egholm, M.
Kozal, M. J. [5 ]
机构：
[1] Univ Minnesota, Minneapolis, MN USA
[2] Univ Illinois, Chicago, IL USA
[3] Wayne State Univ, Detroit, MI USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Cooper Univ Hosp, Camden, NJ 08103 USA
[5] Yale Univ, Sch Med, New Haven, CT USA
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [41] Prevalence and Evolution of Low Frequency HIV Drug Resistance Mutations Detected by Ultra Deep Sequencing in Patients Experiencing First Line Antiretroviral Therapy Failure
    Vandenhende, Marie-Anne
    Bellecave, Pantxika
    Recordon-Pinson, Patricia
    Reigadas, Sandrine
    Bidet, Yannick
    Bruyand, Mathias
    Bonnet, Fabrice
    Lazaro, Estibaliz
    Neau, Didier
    Fleury, Herve
    Dabis, Francois
    Morlat, Philippe
    Masquelier, Bernard
    PLOS ONE, 2014, 9 (01):
  • [42] Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1
    Kosaka, K.
    Imamura, M.
    Hayes, C. N.
    Abe, H.
    Hiraga, N.
    Yoshimi, S.
    Murakami, E.
    Kawaoka, T.
    Tsuge, M.
    Aikata, H.
    Miki, D.
    Ochi, H.
    Matsui, H.
    Kanai, A.
    Inaba, T.
    Chayama, K.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (02) : 158 - 165
  • [43] Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country
    Bourgarit, Anne
    Baron, Gabriel
    Breton, Guillaume
    Tattevin, Pierre
    Katlama, Christine
    Allavena, Clotilde
    Campa, Pauline
    Ravaud, Philippe
    Lortholary, Olivier
    Carcelain, Guislaine
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2015, 12 (08) : 1138 - 1145
  • [44] LONG-TERM FOLLOW-UP OF CHRONIC HEPATITIS C INFECTED PATIENTS TREATED WITH TELAPREVIR: EVALUATION OF PERSISTENCE OF RESISTANT VARIANTS BY ULTRA-DEEP SEQUENCING
    Thomas, X. V.
    de Bruijne, J.
    Kieffer, T. L.
    Sullivan, J. C.
    Rebers, S. P.
    de Vries, M.
    Reesink, H. W.
    Weegink, C. J.
    Molenkamp, R.
    Schinkel, J.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S490 - S491
  • [45] Prevalence of drug-resistant HIV-1 variants in first-line antiretroviral therapy failure: comparison between population- and ultra deep-sequencing, ANRS CO3 Aquitaine cohort, 2000-2008
    Vandenhende, M-A
    Bellecave, P.
    Recordon-Pinson, P.
    Bidet, Y.
    Bruyand, M.
    Bonnet, F.
    Neau, D.
    Lazaro, E.
    Fleury, H.
    Dabis, F.
    Morlat, P.
    Masquelier, B.
    ANTIVIRAL THERAPY, 2010, 15 : A127 - A127
  • [46] Ultra-deep sequencing of the NS3 and NS5B regions detects pre-existing resistant variants to direct acting antivirals (DAA) in HCV genotype 1 infected patients naive
    Margeridon-Thermet, S.
    Le Pogam, S.
    Liu, T. F.
    Hanczaruk, B.
    Arnold, T. E.
    Simen, B.
    Shulman, N.
    Shafer, R. W.
    Najera, I.
    ANTIVIRAL THERAPY, 2011, 16 : A33 - A33
  • [47] ULTRA-DEEP SEQUENCING OF THE NS3 AND NS5B REGIONS DETECTS PRE-EXISTING RESISTANT VARIANTS TO DIRECT ACTING ANTIVIRALS (DAA) IN HCV GENOTYPE 1 INFECTED PATIENTS NAIVE
    Margeridon, Severine
    Le Pogam, Sophie
    Liu, Tommy F.
    Hanczaruk, Bozena
    Arnold, Todd E.
    Simen, Birgitte B.
    Shulman, Nancy
    Shafer, Robert W.
    Najera, Isabel
    HEPATOLOGY, 2010, 52 (04) : 714A - 714A
  • [48] National survey for drug-resistant variants in newly diagnosed antiretroviral drug-naive patients with HIV/AIDS in South Korea: 1999-2005 vs. 2006-2012
    Choi, J-Y
    Park, M.
    Kwon, O-K
    Choi, B. S.
    Kee, M-K
    Kim, S. S.
    ANTIVIRAL THERAPY, 2014, 19 : A63 - A63
  • [49] Low prevalence of transmitted genetic drug resistance in a cohort of HIV infected naive patients entering antiretroviral treatment programs at two sites in northern South Africa
    Nwobegahay, Julius
    Selabe, Gloria
    Ndjeka, Norbert O.
    Manhaeve, Cecile
    Bessong, Pascal Obong
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (12) : 1839 - 1843
  • [50] Persons with virological failure (VF) on an initial boosted-PI regimen infrequently possess low-level variants with major PI drug resistance mutations (DRMs) by ultra-deep sequencing (UDS)
    Lataillade, M.
    Chiarella, J.
    Yang, R.
    Degrosky, M.
    Seekins, D.
    Uy, J.
    McGrath, D.
    Simen, B.
    Egholm, M.
    Kozal, M. J.
    ANTIVIRAL THERAPY, 2010, 15 : A128 - A128
12345